Design Therapeutics (DSGN) Share-based Compensation (IS) (2021 - 2025)
Design Therapeutics' Share-based Compensation (IS) came in at $3.54 million for Q1 2025, up 11.1% from $3.18 million a year earlier.
Powered by 
Analysis
Design Therapeutics (DSGN) Share-based Compensation (IS) (2021 - 2025) Analysis & Trends
Over the trailing twelve months to Mar 31, 2025, Design Therapeutics reported Share-based Compensation (IS) of $13.14 million, up 2.3% year-over-year; for FY2023, it came in at $13.09 million, up 19.8% from FY2022.
- Going back by year, Share-based Compensation (IS) was $10.93 million in FY2022 (+133.0%) and $4.69 million in FY2021.
- The Q1 2025 figure represents the highest quarterly Share-based Compensation (IS) since Q2 2023.
- Year-over-year, Share-based Compensation (IS) increased in three of the last seven quarters, with growth averaging 4.6%.
- The fastest year-over-year change in Share-based Compensation (IS) over five years came in Q1 2022 (growth of 264.8%), and the weakest in Q4 2023 (a decline of 11.4%).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,264.65 Bn | 1,238.27 Bn | 20.46 Bn | - |
| 2 | Johnson & Johnson | 677.74 Bn | 597.60 Bn | 17.30 Bn | - |
| 3 | AbbVie | 517.10 Bn | 485.11 Bn | 13.12 Bn | - |
| 4 | Merck | 362.23 Bn | 325.17 Bn | 13.19 Bn | - |
| 5 | Novartis Ag | 315.90 Bn | 276.16 Bn | 11.24 Bn | - |
| 6 | Astrazeneca | 289.40 Bn | 266.24 Bn | 12.86 Bn | - |
| 7 | Amgen | 249.90 Bn | 201.56 Bn | 7.58 Bn | - |
| 8 | Gilead Sciences | 209.15 Bn | 184.26 Bn | 6.73 Bn | - |
| 9 | Pfizer | 165.88 Bn | 113.23 Bn | 12.56 Bn | - |
| 10 | Design Therapeutics | 678.89 Mn | -179.78 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2025 | 3.54 Mn |
| Sep 30, 2024 | 3.12 Mn |
| Jun 30, 2024 | 3.30 Mn |
| Mar 31, 2024 | 3.18 Mn |
| Dec 31, 2023 | 2.72 Mn |
| Sep 30, 2023 | 3.22 Mn |
| Jun 30, 2023 | 3.72 Mn |
| Mar 31, 2023 | 3.43 Mn |
| Dec 31, 2022 | 3.08 Mn |
| Sep 30, 2022 | 2.87 Mn |
| Jun 30, 2022 | 2.62 Mn |
| Mar 31, 2022 | 2.36 Mn |
| Dec 31, 2021 | 1.56 Mn |
| Sep 30, 2021 | 1.24 Mn |
| Jun 30, 2021 | 1.24 Mn |
| Mar 31, 2021 | 647,000.00 |
API Access
Design Therapeutics Share-based Compensation (IS) API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=share-based-compensation-is&ticker=DSGN&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "share-based-compensation-is", "ticker": "DSGN", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=share-based-compensation-is&ticker=DSGN&period=max&api_key=YOUR_API_KEY");
const data = await res.json();